Literature DB >> 21783674

Impaired behaviour, learning and memory, in adult mice neonatally exposed to hexabromocyclododecane (HBCDD).

Per Eriksson1, Celia Fischer, Maria Wallin, Eva Jakobsson, Anders Fredriksson.   

Abstract

Brominated flame-retardants (BFRs) are a diverse group of global environmental pollutants. In the present study, we show that neonatal exposure to hexabromocyclododecane (HBCDD) can cause developmental behavioural defects that are similar to those recently reported for PBDEs and certain PCBs. Furthermore, HBCDD appears to be as potent as PBDEs in inducing developmental neurotoxic effects in mice. In this study, neonatal NMRI mouse pups were given either a single oral dose of 0.9mg HBCDD/kg body weight, 13.5mg HBCDD/kg body weight, or a 20% fat emulsion vehicle on postnatal day 10. At the age of 3 months, the mice were observed regarding spontaneous behaviour and concerning learning and memory capability. Mice exposed to 0.9mg HBCDD or to 13.5mg HBCDD/kg body weight showed a significantly altered spontaneous behaviour, manifested as a hyperactive condition and reduced habituation. Learning and memory, as observed in a Morris water maze, was also significantly affected in mice given the higher dose of HBCDD.

Entities:  

Year:  2005        PMID: 21783674     DOI: 10.1016/j.etap.2005.10.001

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  21 in total

1.  Utilizing Focus Groups with Potential Participants and Their Parents: An Approach to Inform Study Design in a Large Clinical Trial.

Authors:  Sandeep Kadimpati; Jennifer B McCormick; Yichen Chiu; Ashley B Parker; Aliya Z Iftikhar; Randall P Flick; David O Warner
Journal:  AJOB Empir Bioeth       Date:  2014-01-01

2.  Brominated flame retardants, tetrabromobisphenol A and hexabromocyclododecane, activate mitogen-activated protein kinases (MAPKs) in human natural killer cells.

Authors:  Anita Cato; Lindsay Celada; Esther Caroline Kibakaya; Nadia Simmons; Margaret M Whalen
Journal:  Cell Biol Toxicol       Date:  2014-10-24       Impact factor: 6.691

3.  Impairment in the mesohippocampal dopamine circuit following exposure to the brominated flame retardant, HBCDD.

Authors:  Camille Pham-Lake; Elizabeth B Aronoff; Chad R Camp; Aimee Vester; Sam J Peters; W Michael Caudle
Journal:  Environ Toxicol Pharmacol       Date:  2017-02-04       Impact factor: 4.860

4.  Antioxidant responses in clam Venerupis philippinarum exposed to environmental pollutant hexabromocyclododecane.

Authors:  Hui Zhang; Luqing Pan; Yanxia Tao
Journal:  Environ Sci Pollut Res Int       Date:  2014-03-29       Impact factor: 4.223

5.  NMR- and LC-MS/MS-based urine metabolomic investigation of the subacute effects of hexabromocyclododecane in mice.

Authors:  Dezhen Wang; Ping Zhang; Xinru Wang; Yao Wang; Zhiqiang Zhou; Wentao Zhu
Journal:  Environ Sci Pollut Res Int       Date:  2016-01-20       Impact factor: 4.223

6.  Predictors of tetrabromobisphenol-A (TBBP-A) and hexabromocyclododecanes (HBCD) in milk from Boston mothers.

Authors:  Courtney C Carignan; Mohamed Abou-Elwafa Abdallah; Nerissa Wu; Wendy Heiger-Bernays; Michael D McClean; Stuart Harrad; Thomas F Webster
Journal:  Environ Sci Technol       Date:  2012-10-16       Impact factor: 9.028

7.  Update of the risk assessment of hexabromocyclododecanes (HBCDDs) in food.

Authors:  Dieter Schrenk; Margherita Bignami; Laurent Bodin; James Kevin Chipman; Jesús Del Mazo; Bettina Grasl-Kraupp; Christer Hogstrand; Laurentius Ron Hoogenboom; Jean-Charles Leblanc; Carlo Stefano Nebbia; Elsa Nielsen; Evangelia Ntzani; Annette Petersen; Salomon Sand; Tanja Schwerdtle; Heather Wallace; Diane Benford; Peter Fürst; Martin Rose; Sofia Ioannidou; Marina Nikolič; Luisa Ramos Bordajandi; Christiane Vleminckx
Journal:  EFSA J       Date:  2021-03-08

8.  Prenatal PBDEs and neurodevelopment: animal studies and human health assessment.

Authors:  Marek Banasik
Journal:  Environ Health Perspect       Date:  2010-11       Impact factor: 9.031

9.  Hexabromocyclododecane decreases tumor-cell-binding capacity and cell-surface protein expression of human natural killer cells.

Authors:  Natasha C Hinkson; Margaret M Whalen
Journal:  J Appl Toxicol       Date:  2010-05       Impact factor: 3.446

10.  Acute effects of hexabromocyclododecane on Leydig cell cyclic nucleotide signaling and steroidogenesis in vitro.

Authors:  Svetlana Fa; Kristina Pogrmic-Majkic; Vanja Dakic; Sonja Kaisarevic; Jelena Hrubik; Nebojsa Andric; Stanko S Stojilkovic; Radmila Kovacevic
Journal:  Toxicol Lett       Date:  2013-01-21       Impact factor: 4.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.